hERG Screening Market Size to Hit USD 3.32 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on HERG Screening Market

5.1. COVID-19 Landscape: HERG Screening Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global HERG Screening Market, By Assay Type

8.1. HERG Screening Market, by Assay Type

8.1.1. Binding Assays

8.1.1.1. Market Revenue and Forecast

8.1.2. Functional Assays

8.1.2.1. Market Revenue and Forecast

8.1.3. Manual Patch Clamp

8.1.3.1. Market Revenue and Forecast

8.1.4. Automated Patch Clamp

8.1.4.1. Market Revenue and Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global HERG Screening Market, By Technology

9.1. HERG Screening Market, by Technology

9.1.1. Manual Electrophysiology

9.1.1.1. Market Revenue and Forecast

9.1.2. Automated Electrophysiology Platforms

9.1.2.1. Market Revenue and Forecast

9.1.3. High-Throughput Screening (HTS)

9.1.3.1. Market Revenue and Forecast

9.1.4. Cell-Based Assays

9.1.4.1. Market Revenue and Forecast

9.1.5. Fluorescence Imaging Plate Reader (FLIPR)

9.1.5.1. Market Revenue and Forecast

9.1.6. Technologies

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global HERG Screening Market, By Service Type

10.1. HERG Screening Market, by Service Type

10.1.1. In-House Screening

10.1.1.1. Market Revenue and Forecast

10.1.2. Outsourced Screening Services

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global HERG Screening Market, By End User

11.1. HERG Screening Market, by End User

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Academic & Research Institutions

11.1.2.1. Market Revenue and Forecast

11.1.3. Contract Research Organizations (CROs)

11.1.3.1. Market Revenue and Forecast

11.1.4. Others (Regulatory Bodies, Government Labs, Non-Profits)

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global HERG Screening Market, By Application

12.1. HERG Screening Market, by Application

12.1.1. Lead Optimization

12.1.1.1. Market Revenue and Forecast

12.1.2. Preclinical Safety & Toxicology

12.1.2.1. Market Revenue and Forecast

12.1.3. Regulatory Submission Studies

12.1.3.1. Market Revenue and Forecast

12.1.4. Drug Repositioning Studies

12.1.4.1. Market Revenue and Forecast

12.1.5. Others

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global HERG Screening Market, By Scale of Operation

13.1. HERG Screening Market, by Scale of Operation

13.1.1. Research-Scale Screening

13.1.1.1. Market Revenue and Forecast

13.1.2. Preclinical-Scale Screening

13.1.2.1. Market Revenue and Forecast

13.1.3. High-Throughput Screening Scale

13.1.3.1. Market Revenue and Forecast

Chapter 14. Global HERG Screening Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Assay Type

14.1.2. Market Revenue and Forecast, by Technology

14.1.3. Market Revenue and Forecast, by Service Type

14.1.4. Market Revenue and Forecast, by End User

14.1.5. Market Revenue and Forecast, by Application

14.1.6. Market Revenue and Forecast, by Scale of Operation

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Assay Type

14.1.7.2. Market Revenue and Forecast, by Technology

14.1.7.3. Market Revenue and Forecast, by Service Type

14.1.7.4. Market Revenue and Forecast, by End User

14.1.8. Market Revenue and Forecast, by Application

14.1.8.1. Market Revenue and Forecast, by Scale of Operation

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Assay Type

14.1.9.2. Market Revenue and Forecast, by Technology

14.1.9.3. Market Revenue and Forecast, by Service Type

14.1.9.4. Market Revenue and Forecast, by End User

14.1.10. Market Revenue and Forecast, by Application

14.1.11. Market Revenue and Forecast, by Scale of Operation

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Assay Type

14.2.2. Market Revenue and Forecast, by Technology

14.2.3. Market Revenue and Forecast, by Service Type

14.2.4. Market Revenue and Forecast, by End User

14.2.5. Market Revenue and Forecast, by Application

14.2.6. Market Revenue and Forecast, by Scale of Operation

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Assay Type

14.2.8.2. Market Revenue and Forecast, by Technology

14.2.8.3. Market Revenue and Forecast, by Service Type

14.2.9. Market Revenue and Forecast, by End User

14.2.10. Market Revenue and Forecast, by Application

14.2.10.1. Market Revenue and Forecast, by Scale of Operation

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Assay Type

14.2.11.2. Market Revenue and Forecast, by Technology

14.2.11.3. Market Revenue and Forecast, by Service Type

14.2.12. Market Revenue and Forecast, by End User

14.2.13. Market Revenue and Forecast, by Application

14.2.14. Market Revenue and Forecast, by Scale of Operation

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Assay Type

14.2.15.2. Market Revenue and Forecast, by Technology

14.2.15.3. Market Revenue and Forecast, by Service Type

14.2.15.4. Market Revenue and Forecast, by End User

14.2.16. Market Revenue and Forecast, by Application

14.2.16.1. Market Revenue and Forecast, by Scale of Operation

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Assay Type

14.2.17.2. Market Revenue and Forecast, by Technology

14.2.17.3. Market Revenue and Forecast, by Service Type

14.2.17.4. Market Revenue and Forecast, by End User

14.2.18. Market Revenue and Forecast, by Application

14.2.18.1. Market Revenue and Forecast, by Scale of Operation

14.3. APAC

14.3.1. Market Revenue and Forecast, by Assay Type

14.3.2. Market Revenue and Forecast, by Technology

14.3.3. Market Revenue and Forecast, by Service Type

14.3.4. Market Revenue and Forecast, by End User

14.3.5. Market Revenue and Forecast, by Application

14.3.6. Market Revenue and Forecast, by Scale of Operation

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Assay Type

14.3.7.2. Market Revenue and Forecast, by Technology

14.3.7.3. Market Revenue and Forecast, by Service Type

14.3.7.4. Market Revenue and Forecast, by End User

14.3.8. Market Revenue and Forecast, by Application

14.3.9. Market Revenue and Forecast, by Scale of Operation

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Assay Type

14.3.10.2. Market Revenue and Forecast, by Technology

14.3.10.3. Market Revenue and Forecast, by Service Type

14.3.10.4. Market Revenue and Forecast, by End User

14.3.11. Market Revenue and Forecast, by Application

14.3.11.1. Market Revenue and Forecast, by Scale of Operation

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Assay Type

14.3.12.2. Market Revenue and Forecast, by Technology

14.3.12.3. Market Revenue and Forecast, by Service Type

14.3.12.4. Market Revenue and Forecast, by End User

14.3.12.5. Market Revenue and Forecast, by Application

14.3.12.6. Market Revenue and Forecast, by Scale of Operation

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Assay Type

14.3.13.2. Market Revenue and Forecast, by Technology

14.3.13.3. Market Revenue and Forecast, by Service Type

14.3.13.4. Market Revenue and Forecast, by End User

14.3.13.5. Market Revenue and Forecast, by Application

14.3.13.6. Market Revenue and Forecast, by Scale of Operation

14.4. MEA

14.4.1. Market Revenue and Forecast, by Assay Type

14.4.2. Market Revenue and Forecast, by Technology

14.4.3. Market Revenue and Forecast, by Service Type

14.4.4. Market Revenue and Forecast, by End User

14.4.5. Market Revenue and Forecast, by Application

14.4.6. Market Revenue and Forecast, by Scale of Operation

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Assay Type

14.4.7.2. Market Revenue and Forecast, by Technology

14.4.7.3. Market Revenue and Forecast, by Service Type

14.4.7.4. Market Revenue and Forecast, by End User

14.4.8. Market Revenue and Forecast, by Application

14.4.9. Market Revenue and Forecast, by Scale of Operation

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Assay Type

14.4.10.2. Market Revenue and Forecast, by Technology

14.4.10.3. Market Revenue and Forecast, by Service Type

14.4.10.4. Market Revenue and Forecast, by End User

14.4.11. Market Revenue and Forecast, by Application

14.4.12. Market Revenue and Forecast, by Scale of Operation

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Assay Type

14.4.13.2. Market Revenue and Forecast, by Technology

14.4.13.3. Market Revenue and Forecast, by Service Type

14.4.13.4. Market Revenue and Forecast, by End User

14.4.13.5. Market Revenue and Forecast, by Application

14.4.13.6. Market Revenue and Forecast, by Scale of Operation

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Assay Type

14.4.14.2. Market Revenue and Forecast, by Technology

14.4.14.3. Market Revenue and Forecast, by Service Type

14.4.14.4. Market Revenue and Forecast, by End User

14.4.14.5. Market Revenue and Forecast, by Application

14.4.14.6. Market Revenue and Forecast, by Scale of Operation

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Assay Type

14.5.2. Market Revenue and Forecast, by Technology

14.5.3. Market Revenue and Forecast, by Service Type

14.5.4. Market Revenue and Forecast, by End User

14.5.5. Market Revenue and Forecast, by Application

14.5.6. Market Revenue and Forecast, by Scale of Operation

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Assay Type

14.5.7.2. Market Revenue and Forecast, by Technology

14.5.7.3. Market Revenue and Forecast, by Service Type

14.5.7.4. Market Revenue and Forecast, by End User

14.5.8. Market Revenue and Forecast, by Application

14.5.8.1. Market Revenue and Forecast, by Scale of Operation

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Assay Type

14.5.9.2. Market Revenue and Forecast, by Technology

14.5.9.3. Market Revenue and Forecast, by Service Type

14.5.9.4. Market Revenue and Forecast, by End User

14.5.9.5. Market Revenue and Forecast, by Application

14.5.9.6. Market Revenue and Forecast, by Scale of Operation

Chapter 15. Company Profiles

15.1. Thermo Fisher Scientific

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Nanion Technologies

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Physiologically Relevant

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Corning Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. ChemPartner

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Eurofins Discovery

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Physiologically Relevant

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. NEXEL Co., Ltd.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Cyprotex (Evotec SE)

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Charles River Laboratories

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The hERG screening market size is expected to increase from USD 1.16 billion in 2024 to USD 3.32 billion by 2034.

The hERG screening market is expected to grow at a compound annual growth rate (CAGR) of around 11.10% from 2025 to 2034.

The major players in the hERG screening market include Charles River Laboratories, Eurofins Scientific, Cyprotex (Evotec SE), Thermo Fisher Scientific, Metrion Biosciences, Aurora Biomed, QPatch (Sophion Bioscience), Nanion Technologies, Axol Bioscience, B’SYS GmbH, Multispan Inc., ChanTest, Bioneer Corporation, Cellectricon, Corning Inc., Physiologically Relevant, BioAxis Research, ChemPartner, Eurofins Discovery, and NEXEL Co., Ltd.

The driving factors of the hERG screening market are the rising research and development activities in new drug developments and growing approvals for novel formulations are supporting increased adoption of the hERG screening process.

North America region will lead the global hERG screening market during the forecast period 2025 to 2034.